Tag: Inter Scientific

  • Inter Scientific joins UKVIA

    Inter Scientific joins UKVIA

    Inter Scientific, an analytical testing and regulatory compliance firm, has joined the U.K. Vaping Industry Association (UKVIA).

    “We are thrilled to join UKVIA as a full board member and contribute to the advancement of the vaping industry in the U.K.,” said Inter Scientific CEO David Lawson.

    “At Inter Scientific, we believe in the potential benefits to public that the vape industry holds. Our collaboration with UKVIA will enable us to work closely with industry leaders to ensure the highest standards of safety, quality and compliance are met to benefit consumers and public health.”

    Inter Scientific says it will actively engage in initiatives aligned with the UKVIA’s strategic objectives. “We will uphold the highest quality standards to demonstrate the industry’s responsibility, promote sector growth and its economic contribution,” the company wrote on its website.

    “Addressing misinformation about vaping will be a priority, aiming to correct misconceptions and highlight vaping as a beneficial tool for smoking cessation. Additionally, we aim to foster acceptance and support from the public health community, emphasizing vaping’s role in improving public health outcomes.”

  • Accorto and Inter Scientific Team Up

    Accorto and Inter Scientific Team Up

    From left to right: Vince Angelico: chief scientific officer (Accorto), Jason Krull: chief operating officer (Accorto), Tom Beaudet: CEO (Accorto), Mark Dignum: director (Inter Scientific), Russ Rogers: president (Accorto), David Lawson: director (Inter Scientific)
    Photo: Inter Scientific

    Accorto Regulatory Solutions and Inter Scientific have entered into a strategic alliance agreement to provide single-point regulatory and testing solutions for customers in the nicotine industry and other sectors.

    Based in the U.S., Accorto specializes in helping small- to mid-sized companies navigate the regulatory landscape to bring products that are regulated by the Food and Drug Administration to market. Inter Scientific is an ISO 17025/GMP-compliant testing laboratory and compliance firm based in the U.K.

    The strategic alliance will offer customers in the U.S., Europe, the Middle East and Asia improved access to a Accorto’s regulatory strategy development expertise, FDA regulatory application development and submission services, and project management solutions combined with Inter Scientific’s testing and regulatory compliance expertise in the U.K., Europe and the Middle East.

    The two companies aspire to use this alliance to streamline their clients’ regulatory application development processes, providing a turn-key solution for both regulatory support and associated analytical data development.

    “We are thrilled to unveil our strategic alliance with Accorto,” said Inter Scientific co-founder David Lawson in a statement. “This collaboration represents a significant milestone, offering both new and existing clients a competitive advantage. By aligning with another industry-leading regulatory company that shares the same commitments to quality, urgency, and value, we are confident this will further elevate our standards and capacity.”

     “We could not be more pleased to be entering into our first strategic alliance with a company like Inter Scientific that has such a fantastic team,” said Tom Beaudet, CEO of Accorto. “This not only provides our clients with the ability to collect data needed to prove the safety and efficacy of their products, but also allows us to shorten their regulatory application timelines, giving them a competitive advantage.”